Aflac chairman Lake Charles D II sells $5.69 million in stock

Published 11/03/2025, 22:28
Aflac chairman Lake Charles D II sells $5.69 million in stock

Lake Charles D II, Chairman and Representative Director of Aflac Incorporated (NYSE:AFL), recently sold a significant portion of his holdings in the company. According to a recent SEC filing, Lake sold a total of 52,972 shares of Aflac common stock over two days, with transactions taking place on March 7 and March 10, 2025. The insurance giant, currently valued at $58.19 billion, maintains a strong financial health score according to InvestingPro analysis.

The sales were executed at prices ranging from $106.61 to $108.40 per share, bringing the total value of the transactions to approximately $5.69 million. Following these transactions, Lake holds 49,962 shares in direct ownership and 1,299 shares in a 401(k) plan. The stock currently trades at a P/E ratio of 11.03, with analyst targets ranging from $93 to $122 per share.

The transactions were conducted under a Rule 10b5-1 trading plan, a pre-established plan allowing company insiders to sell stocks at predetermined times, providing a measure of protection against accusations of insider trading. Notably, Aflac has maintained 41 consecutive years of dividend increases, demonstrating strong financial stability. Discover more comprehensive insights and analysis with InvestingPro’s detailed research report.

In other recent news, AFLAC Incorporated reported its fourth-quarter earnings for 2024, revealing a notable earnings per share (EPS) shortfall. The EPS came in at $1.56, falling below the forecasted $1.62, despite strong revenue performance that exceeded expectations with $5.4 billion reported against an anticipated $4.23 billion. Barclays (LON:BARC) responded to these results by lowering its price target on AFLAC to $95.00 from $98.00, maintaining an Underweight rating due to the earnings miss and concerns over the company’s short-term prospects in Japan. Conversely, CFRA increased its price target for AFLAC to $112.00, maintaining a Buy rating, citing a valuation of AFLAC shares at 15.1 times CFRA’s 2026 EPS estimate.

Piper Sandler maintained an Overweight rating on AFLAC, emphasizing the company’s lower risk profile due to less exposure to variable interest entities compared to peers. The firm also highlighted AFLAC’s upcoming cancer insurance product launch in Japan as a potential positive catalyst. Despite the challenges, AFLAC’s investment income showed an 18% increase, helping to offset lower premiums, and the company reported an adjusted EPS growth of 24.8% for the quarter. The insurer’s board declared a first-quarter dividend of $0.58 per share, reaffirming its commitment to shareholder returns through dividends and share repurchases.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.